Pilot study of Flt3 Ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas

Abstract

This study compared the clinical toxicity and hematological effects of i.p. and s.c. administration of fmslike tyroisne kinase-3-ligand, a truncated glycoprotein that increases dendritic cells and monocytes.